<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999232</url>
  </required_header>
  <id_info>
    <org_study_id>Bengmark_v1</org_study_id>
    <nct_id>NCT00999232</nct_id>
  </id_info>
  <brief_title>Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canisius-Wilhelmina Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Canisius-Wilhelmina Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of erythromycin on the Rate of Success in
      Placement of a Self-propelled Feeding Tube.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 48 hours.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 24 hours.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events using this self-propelled tube</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Erythromycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Erythromycin</intervention_name>
    <description>Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube</description>
    <arm_group_label>Erythromycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-80 years

          -  Having pancreatitis

          -  Require jejunal enteral nutrition

        Exclusion Criteria:

          -  Known impaired peristalsis (critically ill patients, postoperative patients, history
             of surgery of the stomach/duodenum)

          -  Pregnancy

          -  Hypersensibility to erythromycin

          -  Cardiac arrhythmias with a prolonged QT-time

          -  Simultaneous usage of drugs impairing peristalsis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>January 21, 2010</last_update_submitted>
  <last_update_submitted_qc>January 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2010</last_update_posted>
  <keyword>erythromycin</keyword>
  <keyword>prokinetics</keyword>
  <keyword>nasojejunal tubes</keyword>
  <keyword>Bengmark feeding tube</keyword>
  <keyword>post-pyloric feeding</keyword>
  <keyword>pancreatitis</keyword>
  <keyword>Non-critically ill patients having pancreatitis who require jejunal enteral nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Erythromycin Estolate</mesh_term>
    <mesh_term>Erythromycin Ethylsuccinate</mesh_term>
    <mesh_term>Erythromycin stearate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

